Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.
Allermi's investors include Shane Neman, Lucas Venture Group, Nelstone Ventures.
Allermi is headquartered in San Francisco, United States.
Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.
Allermi is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allermi — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/allermi. Accessed September 13, 2026.
VCBacked. (2024). Allermi — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/allermi
{{cite web |title=Allermi — Funding & Investors |url=https://www.vcbacked.co/company/allermi |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated